4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-17-000008
CIK 0000899866operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:21 PM ET
Size
43.3 KB
Accession
0000899866-17-000008
Insider Transaction Report
Form 4
PARVEN ALVIN S
Director
Transactions
- Sale
Common Stock, par value $.0001 per share
2017-01-05$133.95/sh−15$2,009→ 5,505 total(indirect: By Spouse) - Sale
Common Stock, par value $.0001 per share
2017-01-05$141.22/sh−22$3,107→ 3,880 total(indirect: By Spouse) - Exercise/Conversion
Option to Purchase Common Stock
2017-01-05−7,932→ 0 totalExercise: $26.64From: 2010-08-12Exp: 2020-05-12→ Common Stock, par value $.0001 per share (7,932 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2017-01-05−5,572→ 0 totalExercise: $49.43From: 2011-08-11Exp: 2021-05-11→ Common Stock, par value $.0001 per share (0 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2017-01-05−3,237→ 0 totalExercise: $85.75From: 2012-08-08Exp: 2022-05-08→ Common Stock, par value $.0001 per share (3,237 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-05$96.35/sh+3,425$329,999→ 26,539 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$133.95/sh−185$24,781→ 26,354 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$137.56/sh−7,375$1,014,505→ 18,610 total - Exercise/Conversion
Option to Purchase Common Stock
2017-01-05−3,425→ 0 totalExercise: $96.35From: 2013-08-07Exp: 2023-05-07→ Common Stock, par value $.0001 per share (3,425 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-05$49.43/sh+5,572$275,424→ 19,877 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$138.60/sh−421$58,351→ 4,454 total(indirect: By Spouse) - Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-05$26.64/sh+7,932$211,308→ 14,305 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-05$85.75/sh+3,237$277,573→ 23,114 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$138.60/sh−5,176$717,394→ 13,434 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$140.59/sh−1,433$201,465→ 6,651 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$135.69/sh−31$4,206→ 5,474 total(indirect: By Spouse) - Sale
Common Stock, par value $.0001 per share
2017-01-05$137.56/sh−599$82,398→ 4,875 total(indirect: By Spouse) - Sale
Common Stock, par value $.0001 per share
2017-01-05$139.49/sh−5,350$746,272→ 8,084 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$141.23/sh−278$39,262→ 6,373 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$139.49/sh−435$60,678→ 4,019 total(indirect: By Spouse) - Sale
Common Stock, par value $.0001 per share
2017-01-05$140.59/sh−117$16,449→ 3,902 total(indirect: By Spouse) - Sale
Common Stock, par value $.0001 per share
2017-01-05$135.70/sh−369$50,073→ 25,985 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$133.65/sh−853$114,003→ 5,520 total(indirect: By Trust)
Footnotes (9)
- [F1]This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.95 - $134.95. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $135.22 - $136.22. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $137.04 - $138.04. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.05 - $139.05. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F6]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $139.08 - $140.08. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F7]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $140.13 - $141.13. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F8]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $141.17 - $142.17. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F9]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $133.65 - $134.65. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:21 PM ET
- Size
- 43.3 KB